What are the most important nursing interventions for clients with possible renal calculi? List two.

Recombinant human erythropoietin is a medication commonly used in the treatment of anemia associated with chronic renal failure. It stimulates the production of red blood cells in the bone marrow, helping to improve anemia.

The other statements mentioned do not accurately reflect the expected outcomes or effects of recombinant human erythropoietin:

Chronic renal failure leads to impaired kidney function, and while recombinant human erythropoietin can help address anemia, it does not directly improve creatinine (Cr) and blood urea nitrogen (BUN) levels, which are markers of kidney function.

Furosemide is a diuretic commonly used in the management of fluid retention in renal failure. Recombinant human erythropoietin does not replace or eliminate the need for diuretic therapy.

Chronic renal failure typically involves decreased kidney function and impaired urine production. Recombinant human erythropoietin does not directly affect urine output.

Vesico-Ureteral Reflux (VUR) is a condition where urine flows backward from the bladder into the ureters and potentially up to the kidneys. This can increase the risk of urinary tract infections (UTIs) and potential kidney damage. By taking antibiotics for a longer duration, the aim is to prevent or reduce the occurrence of UTIs. Antibiotics help to eliminate or control bacterial growth in the urinary tract, reducing the risk of infection and associated complications. It is important to clarify that long-term antibiotic use does not cure VUR but rather helps manage the risk of UTIs.

​​​​​​​